Evido Health and Stavanger University Hospital initiates Eurostars project with 5M DKK in funding

Evido Health
November 29, 2022

Earlier this year, we travelled to Norway to initiate our Eurostars project with Stavanger University Hospital. Together, we will conduct a real-world pilot integrating LiverPRO directly into the existing healthcare infrastructure and clinical workflows to support the early detection of patients with liver fibrosis.

Funded by Eureka and the European Union

This real-world pilot is only possible due to funding from Eureka and the European Union, which have granted the project almost 5M DKK through the Eurostars programme. We are proud and humbled to have secured this grant. It shows that Eureka and the European Union believe in our mission and recognise not only the potential of LiverPRO but also the pressing need that we are addressing.

Evido Health partners with Stavanger University Hospital

Even though this project is at its early phases, our collaboration with Stavanger University Hospital has evolved into a great partnership through the funding application and project planning processes. It is a collaboration that already holds strong proactiveness, expertise, insights, and innovative mindsets, which will enable us to bring better care to clinicians and patients. We are beyond excited about the phases to come.

About LiverPRO

LiverPRO is a medical software technology specifically designed for detecting liver fibrosis amongst people with risk factors. Based on machine learning, LiverPRO uses the results from standard blood tests to predict the level of scar tissue in the liver, i.e., liver fibrosis. The risk score derived from using LiverPRO can be accompanied by a specific clinical recommendation which empowers clinicians with actionable recommendations to streamline the diagnosis and management of the patients.

LiverPRO is an important piece of the puzzle to disrupt the current paradigm around Steatotic Liver Disease (MASH, Met-ALD, ALD) diagnostics, going from reactive to preventive care. LiverPRO is considered a highly innovative solution not only by its advanced technology but also its user-centric approach and scalability, striving for successful implementation and value creation across healthcare systems.

Would you like to learn more?

Gain a better understanding of how LiverPRO can be used and scaled to support you in detecting patients with liver fibrosis early and accurately.

Book a demo